Form 4 for GL Globe Life
Accepted 2026-05-07 15:23:45 ET · period of report 2026-05-06 · accession 0000320335-26-000167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-07 15:23 | 2026-05-06 | GL | HENRIE MICHAEL SHANE | SVP, CAO | M - OptEx | $128.40 | +2,150 | 5,599 | +62% | +$276.1K |
| DM | 2026-05-07 15:23 | 2026-05-06 | GL | HENRIE MICHAEL SHANE | SVP, CAO | S - Sale+OE | $155.19 | -2,150 | 3,449 | -38% | -$333.7K |
| D | 2026-05-07 15:23 | 2026-05-06 | GL | HENRIE MICHAEL SHANE | SVP, CAO | M - OptEx | $0.00 | -2,150 | 2,150 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-06 | M | A | 2,150 | $128.40 | 5,599.08 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-06 | S | D | 1,645 | $155.01 | 3,954.08 | D | — | — | (F1) Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. (F2) Sales at prices ranging from $154.44 per share to $155.35 per share. |
| 3 | Common | Common Stock | 2026-05-06 | S | D | 505 | $155.78 | 3,449.08 | D | — | — | (F1) Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer. (F3) Sales at prices ranging from $155.47 per share to $156.245 per share. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2026-05-06 | M | D | 2,150 | $0.00 | 2,150 | D | $128.40 · — to 2031-02-28 | 2,150 Common Stock | (F4) First exercisable as to 50% of shares 02-28-2026 and as to the remaining 50% of shares 02-28-2027. |